Eosinophilic Airway Diseases: From Pathophysiological Mechanisms to Clinical Practice
International Journal of Molecular Sciences · 14.04.2023 · 24 (8) · 7254
DOI: 10.3390/ijms24087254 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.04.2023. Verfasst von Mauro Mormile und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy. Hauptthemen laut MEDLINE: Asthma, Hypersensitivity, Pulmonary Disease, Chronic Obstructive, Respiration Disorders. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 176 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “Ricerca Corrente” funding scheme of the Ministry of Health.
Abstract (Originalsprache)
Eosinophils play a key role in airway inflammation in many diseases, such as allergic and non-allergic asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. In these chronic disabling conditions, eosinophils contribute to tissue damage, repair, remodeling, and disease persistence through the production a variety of mediators. With the introduction of biological drugs for the treatment of these respiratory diseases, the classification of patients based on clinical characteristics (phenotype) and pathobiological mechanisms (endotype) has become mandatory. This need is particularly evident in severe asthma, where, despite the great scientific efforts to understand the immunological pathways underlying clinical phenotypes, the identification of specific biomarkers defining endotypes or predicting pharmacological response remains unsatisfied. In addition, a significant heterogeneity also exists among patients with other airway diseases. In this review, we describe some of the immunological differences in eosinophilic airway inflammation associated with severe asthma and other airway diseases and how these factors might influence the clinical presentation, with the aim of clarifying when eosinophils play a key pathogenic role and, therefore, represent the preferred therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Medicine and Surgery, University of Naples Federico II, 80131 Naples, Italy.
- Department of Translational Medical Sciences, University of Naples Federico II, 80131 Naples, Italy.
- Istituti Clinici Scientifici Maugeri IRCCS, Pulmonary Rehabilitation Unit of Telese Terme Institute, 82037 Telese Terme, Italy.
- Istituti Clinici Scientifici Maugeri IRCCS, Directorate of Telese Terme Institute, 82037 Telese Terme, Italy.
ORCID-Profile: Ilaria Mormile, Salvatore Fuschillo, Francesca Wanda Rossi, Pasquale Ambrosino, Mauro Maniscalco
Förderung
- “Ricerca Corrente” funding scheme of the Ministry of Health
Zitieren
APA
Mormile, M., Mormile, I., Fuschillo, S., Rossi, F. W., Lamagna, L., Ambrosino, P., de Paulis, A., & Maniscalco, M. (2023). Eosinophilic Airway Diseases: From Pathophysiological Mechanisms to Clinical Practice. International Journal of Molecular Sciences, 24(8), 7254. https://doi.org/10.3390/ijms24087254
Vancouver
Mormile M, Mormile I, Fuschillo S, Rossi FW, Lamagna L, Ambrosino P, et al. Eosinophilic Airway Diseases: From Pathophysiological Mechanisms to Clinical Practice. International Journal of Molecular Sciences. 2023;24(8):7254. doi:10.3390/ijms24087254
BibTeX
@article{Mormile2023,
author = {Mormile, Mauro and Mormile, Ilaria and Fuschillo, Salvatore and Rossi, Francesca Wanda and Lamagna, Laura and Ambrosino, Pasquale and de Paulis, Amato and Maniscalco, Mauro},
title = {Eosinophilic Airway Diseases: From Pathophysiological Mechanisms to Clinical Practice},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {8},
pages = {7254},
doi = {10.3390/ijms24087254}
}
EUVIMED